Skip to content

Health-eBrain Study

Caregivers Virtual Health eBrain Study II

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02903862
Acronym
HeB
Enrollment
0
Registered
2016-09-16
Start date
2016-07-31
Completion date
2017-07-31
Last updated
2018-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression and Burden in Caregivers

Keywords

Caregivers, Case Management, Alzheimer's Disease, Cognition, Caregiver Burden, Depression

Brief summary

The purposes of this study are to (1) track dementia caregiver health indicators over 12 weeks, both with and without the Mindoula plus DANA intervention (case manager and mobile messaging and assessment applications) to determine if the intervention improves caregiver health and (2) obtain feedback from caregivers to inform on the design of future interventions.

Detailed description

This study will track the mental status and cognition of caregivers with and without the Mindoula and DANA intervention and use subject feedback to aid in designing future interventions for caregivers. This is a remotely administered, virtual study targeting dementia caregivers who are mild to moderately depressed. Screening calls for online administration of four surveys to determine inclusion in the study arms. These surveys will be taken on the Health-eBrain website, both at baseline/screening and throughout participation. All other participation will be completed on the participant's mobile phone, and all psychological and cognitive tests will be self-administered. This study has a between-group design. Participants will be screened for eligibility and then randomized into each arm. The intervention arm will receive the Mindoula plus DANA intervention. The wait list control arm will take the psychological surveys at regular intervals then, after 12 weeks, be enrolled in the DANA-only observation group. The DANA-only group will take DANA and a usability questionnaire.

Interventions

BEHAVIORALMindoula

The Mindoula intervention is a combination of case management and a messenger application. Case managers monitor how the participant is doing and any needs and provide 24/7 support & assistance, including care coordination, treatment adherence, and matching the participant with providers and community resources. Each participant will be given an intake questionnaire to establish goals and behavioral health history. Participants will use the app and work with the case manager for 12 weeks.

DEVICEDANA

DANA is an FDA-cleared neurocognitive assessment software administered on a smartphone or tablet to measure changes in cognitive efficiency. DANA also includes Ecological Momentary Assessments to track mood, sleep, stress, and memory. Intervention participants will take DANA weekly. The Waitlist Control arm will take DANA weekly 12 weeks after enrollment.

Sponsors

Bright Focus Foundation
CollaboratorUNKNOWN
Mindoula Health Inc.
CollaboratorUNKNOWN
21st Century Brain Trust
CollaboratorOTHER
Geoffrey Beene Foundation
CollaboratorUNKNOWN
AnthroTronix, Inc.
Lead SponsorINDUSTRY

Study design

Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Females and males who regularly provide care for a person with Alzheimer's Disease * Between the ages of 45-75 * Self-reported ability to speak and read English * Providing care for at least a year Participants in the Intervention and Waitlist Control Arms must meet the following additional inclusion criteria: * Zarit Burden Inventory (ZBI) Score of 9+ * Overall M3 score of 33+ * M3 Depression score of 7+ * Female Only * Minimum hours of caregiving a week must be equal to or greater than 20 hours

Exclusion criteria

* Anyone with a known cognitive diagnosis * Anyone with color blindness * Overall score of high risk on the M3 and/or high risk on the PTSD or Bipolar subsection of the M3 * Failure to meet all inclusion criteria per arm

Design outcomes

Primary

MeasureTime frame
Change from baseline M3 Behavioral Scale score over 12 weeksAt baseline, and 4, 8, and 12 weeks.

Secondary

MeasureTime frame
Change from baseline Zarit Burden Inventory score over 12 weeksAt baseline, and 4, 8, and 12 weeks.
Change from baseline PROMIS Sleep Disturbance Short Form 8a score over 12 weeksAt baseline, and 4, 8, and 12 weeks.

Other

MeasureTime frameDescription
Usability QuestionnaireAt baseline, and 4, 8, and 12 weeks.Survey on using DANA that will help the researchers better understand the development of technologies for this population
Paired Associates LearningAt baseline and 12 weeksThe PAL assesses visual memory and new learning.
PERMA ProfilerAt baseline and 12 weeksThis survey assesses five core element of psychological well-being and happiness - Positive emotions, Engagement, Relationships, Meaning, and Accomplishments - as well as subjective wellbeing and sense of loneliness.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026